TY  - GEN
AU  - Denkert,Carsten
AU  - von Minckwitz,Gunter
AU  - Darb-Esfahani,Silvia
AU  - Lederer,Bianca
AU  - Heppner,Barbara I
AU  - Weber,Karsten E
AU  - Budczies,Jan
AU  - Huober,Jens
AU  - Klauschen,Frederick
AU  - Furlanetto,Jenny
AU  - Schmitt,Wolfgang D
AU  - Blohmer,Jens-Uwe
AU  - Karn,Thomas
AU  - Pfitzner,Berit M
AU  - Kümmel,Sherko
AU  - Engels,Knut
AU  - Schneeweiss,Andreas
AU  - Hartmann,Arndt
AU  - Noske,Aurelia
AU  - Fasching,Peter A
AU  - Jackisch,Christian
AU  - van Mackelenbergh,Marion
AU  - Sinn,Peter
AU  - Schem,Christian
AU  - Hanusch,Claus
AU  - Untch,Michael
AU  - Loibl,Sibylle
TI  - Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy
SN  - 1474-5488
PY  - 2018///1126
KW  - Adult
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - adverse effects
KW  - Biomarkers, Tumor
KW  - analysis
KW  - Breast Neoplasms
KW  - chemistry
KW  - Chemotherapy, Adjuvant
KW  - Disease-Free Survival
KW  - Female
KW  - Humans
KW  - Lymphocytes, Tumor-Infiltrating
KW  - drug effects
KW  - Middle Aged
KW  - Neoadjuvant Therapy
KW  - Randomized Controlled Trials as Topic
KW  - Receptor, ErbB-2
KW  - Risk Factors
KW  - Time Factors
KW  - Treatment Outcome
KW  - Triple Negative Breast Neoplasms
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1016/S1470-2045(17)30904-X
ER  -